Verdiva Bio Completes Enrollment for Phase 2b EVOLVE-2 Study of VRB-101
Verdiva Bio Advances Obesity Therapy with Once-Weekly Oral GLP-1 Peptide Analog Is the pharmaceutical industry on the brink of a breakthrough in obesity treatment? Verdiva Bio Limited a clinical-stage biopharmaceutical company focused on developing innovative therapies for obesity and cardiometabolic…
Greenspace Health Enhances EHR Integration for LACDMH Reporting
Streamlining Compliance and Improving Client Care in Los Angeles County In an era where mental health services are increasingly data-driven, how can organizations ensure they meet regulatory requirements without sacrificing client care? Greenspace Health has the answer. The company, which…
Grove Biopharma Advances Cancer Treatment With Novel Protein-Like Polymers
Preclinical Study Shows Targeted Degradation of MYC and KRAS Using Bionic Biologics Platform Why have traditional cancer treatments struggled to target the most aggressive forms of the disease? Grove Biopharma, a private biotechnology company based in Chicago, is addressing this…
Pearl Dental AI Solutions Partner with DECA Dental Group to Enhance Patient Care
DECA Dental Group Adopts Pearl’s AI to Improve Clinical Outcomes and Patient Engagement In the rapidly evolving landscape of dental technology, the integration of artificial intelligence (AI) is becoming a game-changer. Pearl, the global leader in dental AI solutions, has…
Alluvium Unveils AI-Powered Platform to Transform Health System Access and Capacity
Rebranding and New Platform Reflect Alluvium’s Commitment to Unified Data Management How can health systems navigate the complex challenges of capacity management and revenue optimization? Alluvium, formerly known as BlockIt, is addressing this critical issue with the launch of its…
Allurion Technologies Secures $3.0 Million from Immediate Warrant Exercise
Allurion Technologies Announces Significant Capital Raise Through Warrant Exercise In the rapidly evolving landscape of metabolic health and weight loss, Allurion Technologies, Inc. is making a bold move. The company, a pioneer in metabolically healthy weight loss, has announced a…
Alcanza Clinical Research Wins 2025 HCPEA Impact Award for Inclusive Research
Alcanza Clinical Research Recognized for Advancing Community-Based Clinical Trials How can healthcare organizations ensure that clinical research truly reflects the communities it serves? The Healthcare Private Equity Association (HCPEA) has recognized Alcanza Clinical Research (Alcanza) with its 2025 HCPEA Impact…
VideaHealth Powers Dental AI Transformation for Great Expressions Dental Centers
GEDC Deploys VideaAI Across 210 Practices in Just Two Weeks Is the dental industry ready for a major AI-driven transformation? VideaHealth, the leading dental AI platform, is making waves with its rapid deployment of VideaAI across Great Expressions Dental Centers…
Sarepta Therapeutics Launches ELEVIDYS in Japan for Duchenne Muscular Dystrophy
Sarepta Therapeutics Expands Access to Gene Therapy for Duchenne in Japan Is the future of gene therapy for rare diseases finally within reach? Sarepta Therapeutics, Inc. a leader in precision genetic medicine for rare diseases, has announced the commercial launch…
SolasCure Ltd Advances Chronic Wound Healing With Phase II Trial Success
SolasCure Ltd Demonstrates Superior Wound Healing with Aurase Wound Gel Why are chronic wounds a persistent challenge for healthcare systems, and how can new treatments make a difference? SolasCure Ltd, a biotechnology company focused on transforming chronic wound healing, has…
IntraBio Inc. Secures Orphan Medicinal Product Designation for CACNA1A Disorders
Positive Opinion Paves Way for Phase III Trial of Acetylleucine in Rare Neurological Conditions Why are rare neurological disorders often overlooked in drug development? IntraBio Inc., an Austin, Texas-based global biopharmaceutical company, is addressing this gap by advancing a potential…
Five Discovery Launches to Repair Dysfunctional Brain Circuits in Neurodegenerative Disease
Biotech Firm to Present at Psychedelic Therapeutics Conference in New Orleans Why are current treatments for neurodegenerative diseases often limited to symptom management? Five Discovery, a biotechnology company, is addressing this gap by developing small-molecule therapeutics to repair dysfunctional brain…